Drug Enforcement D-0935-2023

Lack of Assurance of Sterility

Status

Ongoing

Classification

Class II

Report Date

August 2, 2023

Termination Date

Product Information

Product description
Oxacillin for Injection, USP, 1 gram per vial, For IV or IM Use, Rx only, Mfd. for SAGENT Pharmaceuticals, Schaumburg, IL 60195. Made in India. NDC 25021-146-10.
Product quantity
65,710 vials for 1 g and 2 g strength
Reason for recall
Lack of Assurance of Sterility
Recall initiation reason
Initial firm notification
Letter
Distribution pattern
Nationwide in the USA

Location & Firm

Recalling firm
Sagent Pharmaceuticals
Address
1901 N Roselle Rd Ste 450, N/A

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date

Codes & Dates

Recall number
D-0935-2023
Event ID
92678
Recall initiation date
July 11, 2023
Center classification date
July 21, 2023
Code info
Lot: OXG301, Exp 12/31/2025
More code info